|The pharmaceutical and life sciences industry is undergoing a period of profound transformation. Many analysts agree that the industry is moving from the era of the “blockbuster drug” to a new operating model known as personalized medicine. While achieving success in research and development continues to define those who will be the industry’s winners and losers, other issues are increasingly demanding the attention of top management. They include navigating the challenges of global regulatory compliance, optimizing the supply chain, achieving marketing excellence and effectively managing organizational complexity on a global scale. These issues along with increased scrutiny of the industry’s business practices and difficult questions over the safety of marketed drugs have created substantial tensions between the industry and its stakeholders.
Pharmaceuticals Industry Challenges
How PwC can help you
To profitably manage their businesses in this environment, manufacturers will need to consider a new model that embraces fundamental change to the organizational structure, operating practices and corporate culture that prevails in companies today. In the future, successful enterprises will be those that can efficiently adapt to new regulatory requirements, changing markets and develop and sell the next generation of breakthrough therapies while working to ensure that the hard-won bond of trust between the industry and its stakeholders remains strong.